K050273 is an FDA 510(k) clearance for the FRESENIUS ART HEMOADSORPTION SYSTEM. Classified as Separator, Automated, Blood Cell And Plasma, Therapeutic (product code LKN).
Submitted by Fresenius Medical Care North America (Lexington, US). The FDA issued a Cleared decision on June 8, 2005 after a review of 121 days - within the typical 510(k) review window.
This device falls under the Gastroenterology & Urology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.
View all Fresenius Medical Care North America devices